Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Houston, TX

95 studies for Prostate Cancer are recruiting at 137 sites within 50 miles of Houston, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Houston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Houston

Showing the 50 nearest of 95 studies.
  1. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  2. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center (Houston, TX); Ben Taub General Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  3. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson West Houston (Houston, TX); The University of Texas M. D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  4. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

    NCT06470243

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Lyndon Baines Johnson General Hospital (Houston, TX); M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  5. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: MD Anderson West Houston (Houston, TX); UT MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  6. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Houston Metro Urology (Houston, TX); Texas Oncology 1 (Sugar Land, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

    NCT03833921

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Ben Taub General Hospital (Houston, TX); Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Oncology Consultants, P.A. (Houston, TX); University of Texas M.D. Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. A Study of MGC026 in Participants With Advanced Solid Tumors

    NCT06242470

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas MD Anderson Cancer Center (Houston, TX); University of Texas Health Science Center at Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

    NCT06952803

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Research Site (Houston, TX); Research Site (Spring, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson Cancer Center (Houston, TX); NEXT Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: MD Anderson Cancer Center (Houston, TX); Michael E DeBakey VA Medical Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MD Anderson (Houston, TX); NEXT Texas LLC - Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

    NCT01913106

    • Phase 1/2
    • Ages Any age
    • Sex: Male

    Nearest site: Houston Methodist (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

    NCT03541928

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Houston Methodist Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    NCT03972657

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

    NCT04075305

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Md Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT04221542

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

    NCT04503265

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

    NCT04693377

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

    NCT04729114

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Houston Metro Urology (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Michael E. DeBakey VA Medical Center, Houston, TX (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

    NCT04812366

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: U.T. MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

    NCT04947254

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

    NCT04969315

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)

    NCT05043012

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

    NCT05054296

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

    NCT05125016

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: UT MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Comprehensive Outcomes for After Cancer Health

    NCT05349227

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: UT Health Houston (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

    NCT05417594

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

    NCT05422911

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Michael E. DeBakey VA Medical Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

    NCT05454488

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    NCT05489211

    • Phase 2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

    NCT05497024

    • Observational
    • Ages 65 years and older
    • Sex: Male

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Houston Methodist Hospital (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

    NCT05691465

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UT MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    NCT05803941

    • Phase 4
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: UT Health Science Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

    NCT05840484

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

    NCT05873192

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: The University of Texas MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

    NCT05932862

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #1 (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

    NCT05997615

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Investigational Site Number: 401 (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

    NCT06066437

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

    NCT06085664

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: M D Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

    NCT06085729

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    NCT06095089

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: MD Anderson Cancer Center (Houston, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.